Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Barlas

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
P & T : a Peer-Reviewed Journal for Formulary Management|May 9, 2017
New User Fee Agreements Aim at Ensuring Relief From High Drug Prices: But Trump's Budget Proposal Threatens to Upend Completed NegotiationsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2018
CMS Consideration of Rebate Overhaul Elicits Strong Opinions Both Pro and ConStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 5, 2017
Significant Change Coming in 2018 in Tiering Exceptions Policy for Part DStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|October 2, 2018
FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug LabelStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 14, 2019
FTC Gives Generics Victory On "Pay for Delay": Reverse Payments Crimped, Patent Thickets UntouchedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 14, 2019
Are Hospital Prices a Bigger Problem than Drug Prices?: Congress Doesn't Know, Doesn't CareStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 14, 2018
FDA Guidance on 503B Provides Leeway: Outsourcing Facilities Can Be Co-Located With 503A PharmaciesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 14, 2016
CMS to Test Enhanced Medication Therapy Management Model: Aims for Greater Use of Pharmacists, Cost Savings, and Better OutcomesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 2, 2018
CMS Considering Pharmacy Counter Discounts for Part D Drugs in Future Other Pharmacy Changes Are Likely for 2019Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 2, 2018
Vertical Integration Heats Up in Drug Industry: Will Medication Price Hikes Cool Down as a Result?Stephen Barlas
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
P & T : a Peer-Reviewed Journal for Formulary Management|May 9, 2017
New User Fee Agreements Aim at Ensuring Relief From High Drug Prices: But Trump's Budget Proposal Threatens to Upend Completed NegotiationsStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|April 7, 2018
CMS Consideration of Rebate Overhaul Elicits Strong Opinions Both Pro and ConStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 5, 2017
Significant Change Coming in 2018 in Tiering Exceptions Policy for Part DStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|October 2, 2018
FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug LabelStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 14, 2019
FTC Gives Generics Victory On "Pay for Delay": Reverse Payments Crimped, Patent Thickets UntouchedStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|May 14, 2019
Are Hospital Prices a Bigger Problem than Drug Prices?: Congress Doesn't Know, Doesn't CareStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|August 14, 2018
FDA Guidance on 503B Provides Leeway: Outsourcing Facilities Can Be Co-Located With 503A PharmaciesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|July 14, 2016
CMS to Test Enhanced Medication Therapy Management Model: Aims for Greater Use of Pharmacists, Cost Savings, and Better OutcomesStephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|February 2, 2018
CMS Considering Pharmacy Counter Discounts for Part D Drugs in Future Other Pharmacy Changes Are Likely for 2019Stephen Barlas
P & T : a Peer-Reviewed Journal for Formulary Management|January 2, 2018
Vertical Integration Heats Up in Drug Industry: Will Medication Price Hikes Cool Down as a Result?Stephen Barlas
Pageof 15